Lipid Droplet Isolation and Proteomics

A protein in the fraction is not a protein on the droplet.

The Problem With the Fraction

Droplets are less dense than all other organelles, which makes them separable — and also makes them a sink for anything that co-floats: membranes, aggregated protein, vesicles and, in some protocols, the solubilised lipids themselves.

ContaminantMarkerConsequence
Endoplasmic reticulumCalnexin, PDI, Sec61The largest source, because droplets originate there
MitochondriaVDAC, COXIV, TOM20Contacts make this worse
Plasma membraneNa/K-ATPase, cadherinVesicle entrapment
CytosolGAPDH, tubulinIncomplete washing
Lysosome and autophagosomeLAMP1, LC3Genuine contacts, or contamination
Aggregated protein—Co-floats; not separable by density

Important distinction. A protein present in the droplet fraction is not thereby a droplet protein. Enrichment relative to the starting homogenate, and the contamination profile, are what convert a list of proteins into a claim. The ER markers matter most: droplet biogenesis occurs at the ER, so a genuine droplet proteome will contain some ER proteins, and the fraction of ER marker enrichment determines how much of the rest is interpretable.

Part 1 — The Isolation

StepDetailFailure mode
LysisHypotonic, with a protease and phosphatase inhibitor cocktailIncomplete lysis retains intact cells
HomogenisationDounce, gentle, with a nuclei pelleting stepShear disrupts droplets; over-homogenisation fragments membranes
GradientSucrose or iodixanol, typically 0.5–1.0 M bottom layer and low-density topWrong density loses droplets or co-isolates membranes
Ultracentrifugation100,000 × g, 1–2 h, 4 °CTemperature and time affect recovery
CollectionTop fraction, minimal volumeMixing the interface brings contaminants
WashingRepeat flotation onceRepeated washing loses droplets and surface proteins

Caveat on iodixanol versus sucrose. Iodixanol gradients give better separation of droplets from ER membranes in many hands, and are less likely to cause osmotic shrinkage. Sucrose is the historical standard. Whichever is used, the density of the droplet layer should be verified rather than assumed, and the marker profile reported.

Part 2 — Validating the Fraction

CheckMethodExpected
Droplet presenceTriglyceride content; BODIPY on an aliquotEnriched relative to homogenate
ER contaminationCalnexin immunoblotPresent but not dominant
Mitochondrial contaminationVDAC immunoblotLow in a clean preparation
Cytosolic contaminationGAPDH immunoblotLow
Protein yieldBCA or similarRecorded; low yield means losses
MorphologyElectron microscopyIntact droplets, minimal vesicle contamination

Readout note. Reporting the immunoblot profile of three or four markers alongside the proteomics data takes an afternoon and is the difference between a dataset that can be interpreted and one that cannot. Reviewers increasingly ask for it, and the papers that lack it are the ones that fail replication.

Part 3 — Proteomics Design

DecisionOptionsConsequence
QuantificationLabel-free, TMT, SILACLabel-free is common; TMT gives better multiplexing
ComparisonDroplet fraction versus homogenateEnrichment, not abundance
ReplicatesAt least three biologicalOne preparation cannot distinguish a protein from a contaminant
FilteringExclude proteins also enriched in a control membrane fractionReduces false positives
ValidationImaging or immunoblot for selected hitsRequired for any functional claim
ReportingFull list with enrichment values and contamination profileAllows comparison between studies

Caveat on "the droplet proteome". Published droplet proteomes differ substantially in size, from a few hundred to several thousand proteins, and the differences track the preparation method as much as the biology. This is why the isolation protocol, the gradient and the filtering criteria belong in the paper rather than in a supplement.

Part 4 — From List to Claim

ClaimRequiresNot sufficient
"Protein X localises to droplets"Enrichment plus imaging in intact cellsProteomics detection
"Protein X is a droplet protein"Imaging, plus a functional or binding readoutLocalisation alone
"Droplet composition changed"Quantitative comparison across conditions, with contamination markers constantA list from treated cells
"Protein X recruits Y to droplets"Perturbation of X with Y localisation measuredCo-occurrence in a list

Important distinction. Localisation is not function. A protein detected on droplets may be there for degradation, for storage, or incidentally. The functional claim requires its own experiment, and the proteomics is a hypothesis generator for that experiment, not a substitute for it.

Part 5 — Common Failures

  • • No contamination markers reported.
  • • Single preparation used for a proteome list.
  • • Detergent in the lysis buffer, which dissolves droplets.
  • • Over-homogenisation, fragmenting droplets and co-isolating membranes.
  • • Gradient density assumed rather than verified.
  • • Enrichment not computed, so abundance and localisation are conflated.
  • • A proteome list presented as a functional finding.
  • • Conditions compared without re-checking the contamination profile, which may itself have changed.

Part 6 — Where This Article Connects

This is the proteomics companion to the droplet biology article, which covers perilipins and turnover. It connects to the phospholipid article for membrane contamination, to the triglyceride assay for fraction validation, and to the imaging articles in this cluster, which supply the localisation confirmation that proteomics cannot.

If you need droplet fractions with validated contamination profiles and imaging confirmation of hits, we can scope the study with you.

Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Isolation efficiency, contamination and protein recovery vary with cell type, gradient and homogenisation; the protocol should be reported in enough detail to be reproduced.

Detection in a droplet fraction does not establish localisation in intact cells, and localisation does not establish function.

Scientific interpretation and experimental design

  • • The ER is the main contaminant. Droplets come from it.
  • • Report markers. Three blots, one afternoon, most of the credibility.
  • • Enrichment, not abundance. Compare with homogenate.
  • • Three biological replicates minimum.
  • • No detergent in lysis. It dissolves the object.
  • • Proteomics generates hypotheses. Imaging and perturbation test them.

Selected references for further reading

  • • Brasaemle DL, Wolins NE. Isolation of lipid droplets from cells by density gradient centrifugation. Current Protocols in Cell Biology. 2016;72:3.15.1–3.15.13.
  • • Bersuker K, et al. A proximity labeling strategy provides insights into the composition and dynamics of lipid droplet proteomes. Developmental Cell. 2018;44:97–112.
  • • Olzmann JA, Carvalho P. Dynamics and functions of lipid droplets. Nature Reviews Molecular Cell Biology. 2019;20:137–155.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: